Reprint

Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition

Edited by
October 2025
320 pages
  • ISBN 978-3-7258-5281-9 (Hardback)
  • ISBN 978-3-7258-5282-6 (PDF)
https://doi.org/10.3390/books978-3-7258-5282-6 (registering)

Print copies available soon

This is a Reprint of the Special Issue Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition that was published in

Biology & Life Sciences
Medicine & Pharmacology
Chemistry & Materials Science
Summary

Over the past decades, the field of nanomedicine has emerged as a cornerstone of modern drug delivery, offering innovative strategies to overcome the limitations of conventional pharmaceutical formulations. By enabling the encapsulation of poorly soluble drugs and allowing precise control over drug release kinetics and nanoparticle biodistribution, nanomedicines enhance targeted delivery to specific tissues, significantly reducing systemic toxicity while improving therapeutic efficacy. Moreover, these platforms protect fragile bioactive molecules, such as proteins and RNA, from degradation, opening new opportunities for advanced and personalized therapies. This Reprint presents a curated collection of original research articles and review papers focused on the development, engineering, and characterization of cutting-edge nanomedicines, with a particular emphasis on their application in anticancer and anti-infectious treatments.

Related Books

The recommendations have been generated using an AI system.